These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7813076)

  • 21. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.
    Malinow MR; Kang SS; Taylor LM; Wong PW; Coull B; Inahara T; Mukerjee D; Sexton G; Upson B
    Circulation; 1989 Jun; 79(6):1180-8. PubMed ID: 2785871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.
    Robinson K; Arheart K; Refsum H; Brattström L; Boers G; Ueland P; Rubba P; Palma-Reis R; Meleady R; Daly L; Witteman J; Graham I
    Circulation; 1998 Feb; 97(5):437-43. PubMed ID: 9490237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B vitamins and homocysteine in cardiovascular disease and aging.
    Wilcken DE; Wilcken B
    Ann N Y Acad Sci; 1998 Nov; 854():361-70. PubMed ID: 9928444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between plasma homocyst(e)ine and aortic atherosclerosis.
    Konecky N; Malinow MR; Tunick PA; Freedberg RS; Rosenzweig BP; Katz ES; Hess DL; Upson B; Leung B; Perez J; Kronzon I
    Am Heart J; 1997 May; 133(5):534-40. PubMed ID: 9141375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol/L.
    Hackam DG; Peterson JC; Spence JD
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):105-10. PubMed ID: 10678280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial.
    Sesmilo G; Biller BM; Llevadot J; Hayden D; Hanson G; Rifai N; Klibanski A
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1518-24. PubMed ID: 11297577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease.
    Malinow MR; Ducimetiere P; Luc G; Evans AE; Arveiler D; Cambien F; Upson BM
    Atherosclerosis; 1996 Sep; 126(1):27-34. PubMed ID: 8879431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.
    Nallamothu BK; Fendrick AM; Omenn GS
    Pharmacoeconomics; 2002; 20(7):429-42. PubMed ID: 12093299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperhomocyst(e)inemia is associated with carotid atherosclerosis.
    Lupattelli G; Rufini S; Locati EH; Lombardini R; Ciuffetti G; Siepi D; Mannarino E
    Angiology; 1999 Oct; 50(10):823-30. PubMed ID: 10535721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of plasma homocyst(e)ine in arterial occlusive diseases.
    Malinow MR; Stampfer MJ
    Clin Chem; 1994 Jun; 40(6):857-8. PubMed ID: 8087977
    [No Abstract]   [Full Text] [Related]  

  • 31. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
    Lee YK; Kwon YJ; Yoon JW; Oh KS; Cha DR; Cho WY; Huh K; Pyo HJ; Kim HK
    J Korean Med Sci; 1999 Apr; 14(2):193-8. PubMed ID: 10331567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homocysteine as a novel risk factor for atherosclerosis.
    Guthikonda S; Haynes WG
    Curr Opin Cardiol; 1999 Jul; 14(4):283-91. PubMed ID: 10448607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma folic acid cutoff value, derived from its relationship with homocyst(e)ine.
    Brouwer DA; Welten HT; Reijngoud DJ; van Doormaal JJ; Muskiet FA
    Clin Chem; 1998 Jul; 44(7):1545-50. PubMed ID: 9665436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homocyst(e)ine, vitamins and genetic interactions in vascular disease.
    Malinow MR
    Can J Cardiol; 1999 Apr; 15 Suppl B():31B-34B. PubMed ID: 10350683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between maternal and neonatal umbilical cord plasma homocyst(e)ine suggests a potential role for maternal homocyst(e)ine in fetal metabolism.
    Malinow MR; Rajkovic A; Duell PB; Hess DL; Upson BM
    Am J Obstet Gynecol; 1998 Feb; 178(2):228-33. PubMed ID: 9500479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of D-penicillamine on protein-bound homocyst(e)ine in homocystinurics.
    Kang SS; Wong PW; Curley K
    Pediatr Res; 1982 May; 16(5):370-2. PubMed ID: 7099755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of folic acid, pyridoxal phosphate and cobalamin on plasma homocyst(e)ine levels and the susceptibility of low-density lipoprotein to ex-vivo oxidation.
    Weiss N; Feussner A; Hailer S; Spengel FA; Keller C; Wolfram G
    Eur J Med Res; 1999 Oct; 4(10):425-32. PubMed ID: 10527956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
    Ducloux D; Fournier V; Rebibou JM; Bresson-Vautrin C; Gibey R; Chalopin JM
    Clin Nephrol; 1998 Apr; 49(4):232-5. PubMed ID: 9582553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total homocyst(e)ine in plasma and amniotic fluid of pregnant women.
    Kang SS; Wong PW; Zhou JM; Cook HY
    Metabolism; 1986 Oct; 35(10):889-91. PubMed ID: 3762398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease.
    van den Berg M; Stehouwer CD; Bierdrager E; Rauwerda JA
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):165-71. PubMed ID: 8548418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.